Ticker Report Shares of Neurogene Inc. (NASDAQ:NGNE - Get Free Report) have received a consensus recommendation of "Buy" from the nine ratings firms that are currently covering the company, MarketBeat.com reports...\n more…
Ticker Report Neurogene Inc. (NASDAQ:NGNE - Free Report) - Investment analysts at HC Wainwright dropped their Q3 2024 earnings per share estimates for shares of Neurogene in a report issued on Monday, August 12th...\n more…
Ticker Report Shares of Neurogene Inc. (NASDAQ:NGNE - Get Free Report) have earned an average rating of "Buy" from the nine brokerages that are currently covering the stock, MarketBeat reports. Eight research...\n more…